Kirr Marbach Partners Value Fund (KMVAX) is a small-cap value mutual fund focused on undervalued equities primarily in the U.S. market. The fund employs a disciplined investment strategy that emphasizes fundamental analysis and long-term value creation, which positions it uniquely against peers that may chase growth at any cost.
The fund generates revenue primarily through management fees based on AUM, which are typically around 1% annually. Its competitive advantage lies in its rigorous value-oriented investment philosophy and a strong track record of outperforming benchmarks over the long term.
Changes in AUM driven by market performance and investor inflows/outflows
Shifts in investor sentiment towards value investing
Performance relative to benchmarks like the S&P 500
Regulatory changes affecting asset management fees
Increased competition from passive investment vehicles like ETFs
Regulatory changes that could impact fee structures
Pressure from lower-cost index funds and ETFs
Market volatility that may deter investors from active management
Minimal debt levels, but potential liquidity risks if AUM declines significantly
moderate - The fund's performance is somewhat linked to the economic cycle, as economic growth can influence investor sentiment and AUM.
Rising interest rates can lead to increased costs of capital for companies, impacting valuations and potentially reducing AUM as investors seek safer assets. However, higher rates may also attract more conservative investors to value funds.
minimal - The fund does not rely heavily on credit markets for its operations.
value - The fund appeals to investors seeking long-term capital appreciation through a disciplined value investing approach.
moderate - Historical volatility is in line with the broader market, reflecting both the risks and rewards of value investing.